Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
06/2002
06/05/2002EP1210328A1 Fused pyrrolecarboxamides: a new class of gaba brain receptor ligands
06/05/2002EP1210088A1 2-amino-benzoxazinones for the treatment of herpes simplex virus
06/05/2002EP0891336B1 Substituted 1-methyl-3-benzyluracils
06/05/2002EP0711282B1 Compounds as pde iv and tnf inhibitors
06/05/2002EP0629199B1 Indole derivatives as 5-ht1 agonists
06/05/2002CN1352642A Farnesyl protein transferase inhibitors
06/05/2002CN1352639A Novel tricyclic compounds and their use in medicine, process for their production and pharmaceutical composition containing them
06/05/2002CN1352545A 吲哚衍生物 Indole derivatives
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/04/2002USRE37729 Useful as antipsychotic and analgesic agents.
06/04/2002US6399784 Efficient method for the conversion of nitriles to amidines
06/04/2002US6399783 Chemical intermediate for taxol
06/04/2002US6399773 Autoimmune disease; transplanting organs
06/04/2002US6399644 Anticoagulants
06/04/2002US6399639 Administering a 2,4-thiadiazolidinedione compound
06/04/2002US6399629 Efflux pump inhibitors
06/04/2002US6399603 Therapeutic heterocycles
06/04/2002US6399602 Anticancer agents
06/04/2002US6399598 Diheterocyclic metalloprotease inhibitors
06/04/2002US6399047 Benzoxazole derivatives for use in cosmetic compositions and for stabilizing synthetic polymers
06/04/2002CA2248366C Quinoxalinediones
06/04/2002CA2205198C Human neutrophil elastase inhibitors
06/04/2002CA2060557C (quinolin-2-ylmethoxy) indoles as inhibitors of the biosynthesis of leukotrienes
05/2002
05/30/2002WO2002043449A1 Luminescent element material and luminescent element comprising the same
05/30/2002WO2002042297A1 Piperidine compounds and medicinal use thereof
05/30/2002WO2002042296A1 Farnesyl transferase inhibiting benzoheterocyclic derivatives
05/30/2002WO2002042285A1 Novel process for the preparation of 4-benzoylamino chroman derivatives
05/30/2002WO2002042277A1 Novel compounds for use as hiv protease inhibitors
05/30/2002WO2002042275A1 2-aryl-5-trifluoromethylpyridines
05/30/2002WO2002041910A2 Methods and compositions for the treatment of diseases of the eye
05/30/2002WO2002041889A2 Indolsulfonyl compounds useful in the treatment of cns disorders
05/30/2002WO2002041843A2 Antiinflammation agents
05/30/2002WO2002022599A3 Chemokine receptor binding heterocyclic compounds
05/30/2002WO2001098270A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
05/30/2002WO2001087862A3 Biologically active 4h-benzo[1,4]oxazin-3-ones
05/30/2002WO2000076489A3 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
05/30/2002WO2000066581A8 Cyanopyrroles as progesterone receptor agonists
05/30/2002US20020065418 Viral polymerase inhibitors
05/30/2002US20020065415 For treating cerebral ischemia or cerebral infarction resulting from thromboembolic or hemorrhagic stroke, cerebral vasospasms, hypoglycemia, cardiac arrest, neurodegenerative disorders
05/30/2002US20020065285 Aromatic heterocyclic compounds as antiinflammatory agents
05/30/2002US20020065283 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
05/30/2002US20020065280 Oxazolidinones to treat eye infections
05/30/2002US20020065279 Arylsulfonic acid salts of pyrimidine-based antiviral
05/30/2002US20020065276 N-triazolymethyl-piperazine compounds with neurokinin-receptor antagonist activity
05/30/2002US20020065274 Methods of using novel compounds as neuro-protective agents
05/30/2002US20020065230 Bis(aminomethyl)carbonyl compounds as inhibitors of cysteine protease (cathepsin K) and serine proteases; bone or cartilage loss, e.g., osteoporosis, periodontitis; antiarthritic agents; rheumatic diseases; gingivitis
05/30/2002CA2428459A1 Novel compounds for use as hiv protease inhibitors
05/30/2002CA2427334A1 Methods and compositions for the treatment of diseases of the eye
05/30/2002CA2427284A1 Antiinflammation agents
05/29/2002EP1208099A1 4,5-diaryloxazole compounds with prostaglandin i2 (pgi2) agonistic activity
05/29/2002EP1208097A2 Substituted oxoazaheterocyclyl compounds
05/29/2002EP1208092A1 Sulfonamide derivative as a matrix metalloproteinase inhibitor
05/29/2002EP1208090A1 Herbicidaltetrazolinone derivatives
05/29/2002EP1208085A2 Benzanilides as potassium channel openers
05/29/2002EP1070076A4 Chiral separations of pyrimidines
05/29/2002EP0889885B1 Method for selective protection of baccatin derivatives and its application to taxane synthesis
05/29/2002EP0786457B1 Azole derivatives
05/29/2002CN1351602A New pharmaceutically active compounds
05/29/2002CN1351601A Heterocyclic compounds binding chemotactic factor receptor
05/29/2002CN1351595A Substituted polycyclic aryl and heteroacryl pyrazinones useful for selective inhibition of the coagulation cascade
05/29/2002CN1351592A Acyl derivatives which treat VL4-4 related disorders
05/29/2002CN1351590A Compounds
05/29/2002CN1351497A Aminopyrimidines as sorbitol dehydrogenase inhibitors
05/29/2002CN1085663C Aromatic amino ethers as pain relieving agents
05/28/2002US6395897 Drugs for enzyme inhibitors anticoagulants and treatment of autoimmune disease
05/28/2002US6395896 Pyridazine derivatives, manufacturing method and related composition
05/28/2002US6395766 Cognition activators
05/28/2002US6395763 Antitumor, anticancer agents; immunosuppressant
05/28/2002US6395732 Bactericides
05/28/2002US6395724 Multibinding inhibitors of cyclooxygenase-2
05/23/2002WO2002040475A1 Bombesin receptor antagonists
05/23/2002WO2002040471A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002WO2002040469A1 Bombesin receptor antagonists
05/23/2002WO2002040466A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
05/23/2002WO2002040458A1 Isoxazole derivatives
05/23/2002WO2002040456A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor
05/23/2002WO2002040455A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
05/23/2002WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors
05/23/2002WO2002040449A1 Dihydroisoquinolines as novel phosphodiesterase inhibitors
05/23/2002WO2002040445A1 Glucagon antagonists/inverse agonists
05/23/2002WO2002040022A1 Treatment of sexual dysfunction using bombesin antagonist
05/23/2002WO2002040008A2 Treatment of sexual dysfunction with non peptide bombesin receptor antagonists
05/23/2002WO2002008203A3 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by vla-4
05/23/2002WO2001081340A3 Heterocycles that are inhibitors of impdh enzyme
05/23/2002WO2001081316A3 Substituted phenyl farnesyltransferase inhibitors
05/23/2002WO2001079180A3 5-substituted tetralones as inhibitors of ras farnesyl transferase
05/23/2002WO2001074344A3 Small organic molecule regulators of cell proliferation
05/23/2002WO2001042179A9 Compounds which mimic the chemical and biological properties of discodermolide
05/23/2002WO2000063204A3 Substituted azoles
05/23/2002US20020062004 Enantioselective hydrogenation
05/23/2002US20020061917 Efficient process for the preparation of a factor Xa inhibitor
05/23/2002US20020061913 Bicyclic amine derivatives
05/23/2002US20020061912 Piperidinylmethyloxazolidinone derivative
05/23/2002US20020061891 Indole derivatives as 5-HT1B and 5-HT1D agonists
05/23/2002US20020061887 For therapy and prophylaxis of cardiovascular diseases such as hypertension, angina pectoris, cardiac insufficiency, thromboses or atherosclerosis
05/23/2002US20020061881 Compounds, compositions, and methods for stimulating neuronal growth and elongation
05/23/2002US20020061877 Substituted cyclic amine metalloprotease inhibitors
05/23/2002DE10057911A1 New heterocyclic acylsulfimide derivatives, useful as insecticides, acaricides and nematocides for plant protection or in veterinary medicine
05/23/2002DE10054019A1 Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel New substituted indolinones, their preparation and their use as medicaments
05/23/2002CA2448729A1 Piperazinyl and piperidyl substituted heterocyclic compounds